A detailed history of Zurich Insurance Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Zurich Insurance Group LTD holds 376,336 shares of ABBV stock, worth $62.7 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
376,336
Previous 492,110 23.53%
Holding current value
$62.7 Million
Previous $84.4 Million 11.95%
% of portfolio
0.65%
Previous 0.75%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $19 Million - $23.1 Million
-115,774 Reduced 23.53%
376,336 $74.3 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $35.1 Million - $41 Million
-227,025 Reduced 31.57%
492,110 $84.4 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $60.3 Million - $68.7 Million
377,299 Added 110.37%
719,135 $131 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $75.5 Million - $85 Million
-548,547 Reduced 61.61%
341,836 $53 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $119 Million - $138 Million
890,383 New
890,383 $133 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $25.3 Million - $29.1 Million
174,757 New
174,757 $27.9 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $43.6 Million - $66.1 Million
-675,728 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $27.6 Million - $34.5 Million
382,388 Added 130.36%
675,728 $59.8 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $2.56 Million - $3.08 Million
40,614 Added 16.07%
293,340 $22.2 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $2.82 Million - $3.6 Million
-42,907 Reduced 14.51%
252,726 $18.4 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $4.17 Million - $4.91 Million
54,104 Added 22.4%
295,633 $23.8 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $831,204 - $1.03 Million
-10,677 Reduced 4.23%
241,529 $22.3 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $730,751 - $812,365
8,219 Added 3.37%
252,206 $23.9 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $5.62 Million - $6.65 Million
-62,631 Reduced 20.43%
243,987 $22.6 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $1.34 Million - $1.8 Million
-14,606 Reduced 4.55%
306,618 $29 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $10.3 Million - $11.3 Million
115,076 Added 55.82%
321,224 $31.1 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $14.4 Million - $18.4 Million
206,148
206,148 $18.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $295B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Zurich Insurance Group LTD Portfolio

Follow Zurich Insurance Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.